Rheumnow Podcast (Dr. Cush)

Dr. Mrinalini Dey discusses abstract OP0202 presented at Eular 2024 in Vienna, Austria.

This Tuesday Nite Rheumatology was an hour long panel discussion featuring Drs. Janet Pope, Jeff Curtis, Jon Giles and Roy Fleischmann. They reviewed the results and interpretations of the Oral Surveillance Study, Rheumatologists responses to a survey on this study and fielded questions from a Rheumatologist audience. Recorded 9/5/23.

Dr. Jack Cush reviews the news, regulatory updates and journal reports from the past week on RheumNow.com. This week gout worries, mortality risks, measuring anti-drug antibodies and a better way in lupus?

Advancing Telehealth in Rheumatology Dr. Cush at ACR22 Convergence in Philadelphia, PA.

Artificial Intelligence in Detecting Sacroiliitis Dr. Akhil Sood discusses Abstract 0383 at ACR22 Convergence. Abstract 0383: Analysis of the Performance of an Artificial Intelligence Algorithm for the Detection of Radiographic Sacroiliitis in an Independent Cohort of axSpA Patients Including Both Nr-axSpA and r-axSpA

COVID Highlights Dr. Leonard Calabrese and Dr. Cassandra Calabrese share highlights on COVID data being presented at ACR22 Convergence. Abstract 0793: Autonomic Nervous System Dysfunction Common Among Patients with Long COVID: An Exploratory Evaluation Abstract L08: Breakthrough Acute COVID-19 Infection During the US Omicron Surge Following Administration of Tixagevimab/Cilgavimab in Immunocompromised Patients with Rheumatologic Disorders

Impact of COVID 19 on Pregnancies in Women with RMD Dr. Cassy Sims discusses abstract 0950 at ACR22 Convergence. Abstract 0950: Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status: Data from the COVID-19 Global Rheumatology Alliance Registry

Photovoice: A New Visual Research Method in Lupus Dr. Bella Mehta talks with Dr. Candace Feldman about Abstract 1099 at ACR22 Convergence. Abstract 1099: Empowering Patients with Lupus Through Their Photographs: Application of the Photovoice Method to Understand Social Determinants of Health

PreRA to Treat or Not! Dr. Janet Pope discusses the Great Debate at ACR22 Convergence in Philadelphia. 

Prescribing Methotrexate in Post-Roe Era   Dr. Cassy Sims reports live from ACR22 Convergence in Philadelphia, PA. L09: Impact on Access to Methotrexate in the Post-Roe Era

To Switch or Not: Biosimilars in Inflammatory Arthritis Dr. Jonathan Kay reports on abstract 1112 at ACR22 Convergence.  

Women vs. Men: Response to Treatment in Seronegative Arthritis Dr. Janet Pope discusses abstracts 1614 and 1601 at ACR22 Convergence in Philadelphia, PA

Town Hall - Creating Change

Join us as we conclude our Women in Rheumatology campaign by focusing on what's next. Our panelists will recap the major challenges addressed this month and discuss a strategy to continue supporting women in rheumatology.

Speakers: Dr. Kathryn H. Dao, MD Dr. Rachel Tate, DO Dr. Gwenesta B. Melton, MD

Moderator: Jack Cush, MD

Featuring Drs. Artie Kavanaugh and Jack Cush Discussion of highlights from the EULAR 2024 Meeting in Vienna

Dr. Jack Cush goes off on "Untitling" (not using proper names/titles) in the clinic, in additon to reports on rheumatologist salaries, new drugs in phase 1-3 development and the range of COVID-19 MSK symptoms -- all from the past week on RheumNow.com.

Preventive Window of Opportunity in RA? Dr. Aurelie Najm Iberdomide for Lupus: Dr. Kathryn Dao Increased Risk of MACE in Lupus After Noncardiac Surgery: Dr. Kathryn Dao Peripheral SpA: Dr. Antoni Chan and Dr. Nelly Ziade Complications of Covid19 in Lupus: Dr. Kathryn Dao Dose Tapering of TNFi in AxSpA: Dr. Antoni Chan Dr. Yuzaiful Yusof: Factors Associated with Poor Vaccine Response in Rituximabe-treated Patients

ACR22 Daily Recap: Saturday Recap New Treatments for SLE?

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com

Dr. Jack Cush reviews selected AOSD & systemic JIA abstracts from the ACR 2023 Annual meeting held in San Diego, November 12th thru 16th.

Join us for session highlights from RheumNow Live 2024. This webinar will feature highlights from these lectures followed by live audience Q & A:

Rethinking Pre-Clinical Disease in Lupus David Karp, MD

Biology and Rx of Lupus Flares Michelle Kahlenberg, MD

Current/Future Biomarkers in SLE Andrea Fava, MD

Dr. Jack Cush has advise for Cesar and the superstitious and covers pregnancy, platelets, dialysis and vaccinations in Lupus.

https://www.youtube.com/watch?v=XoJIcGZT58A&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=64&t=4s Featuring Drs. Jack Cush, Kathryn Dao and Yuz Yusof reporting on lupus-related studies and sessions from EULAR 2022.

Join Dr. Michael Weisman, Dr. Bella Mehta and Dr. Jack Cush in this live, one-hour Journal Club to discuss:

1. Still's disease in the adult. EGL Bywaters. Annals of Rheumatic Disease 1971 2. Juvenile rheumatoid arthritis presenting in the adult as fever of unknown origin. J Bujak, et al. Medicine 1973

QD183 - Moll & Wright - Right or Wrong? QD184 - What to Do-Do-Do About the DIPs? QD185 - Rheum Comanagement of Psoriasis

RheumNow's PsA Campaign with enhanced coverage of Psoriatic Disease is sponsored by Janssen. All content is chosen by RheumNow + its faculty.

Dr. Jack Frost reviews the news and journal reports with a bonus audience question at the end.

Drs. Pendleton Wickersham (Arthritis Associates PA, San Antonio, TX), Kevin Winthrop (OHSU, Portland, OR), and Christopher Ritchlin (URMC, Rochester, NY) come together to share their experiences discussing with patients the benefit-risk of a JAK inhibitor.

Rheumatologists Dr. Jeffrey Curtis and Dr. Jon Giles discuss the risk of comorbidities that can occur as a consequence of uncontrolled inflammation in RA

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com

Dr. Jack Cush answers audience clinical case questions sent by email or "ask Cush anything". Cases and questions from: Dr. William Hong - RA management in the setting of active TB or latent TB (LTBI) Dr. Vrishali Dalvi - relapsing polychondritis monitoring Dr. Ken Stark - ICI induced RA; management and breast cancer considerations Dr. Nada Skaf - Sarcoidosis in the maxilla Dr. Cush - acute onset (knee) monarthritis

Bimekizumab in Active AS_ 5 Year Study INVIGORATE-1 Study_ IV Secukinumab for Treatment of Active axSpA Overlap of Inflammatory and Degenerative Features in Radiographic axSpA People with AxSpa Need More Sleep

Advancing Telehealth in Rheumatology Dr. Cush at ACR22 Convergence in Philadelphia, PA.

Artificial Intelligence in Detecting Sacroiliitis Dr. Akhil Sood discusses Abstract 0383 at ACR22 Convergence. Abstract 0383: Analysis of the Performance of an Artificial Intelligence Algorithm for the Detection of Radiographic Sacroiliitis in an Independent Cohort of axSpA Patients Including Both Nr-axSpA and r-axSpA

COVID HighlightsDr. Leonard Calabrese and Dr. Cassandra Calabrese share highlights on COVID data being presented at ACR22 Convergence Abstract 0793: Autonomic Nervous System Dysfunction Common Among Patients with Long COVID: An Exploratory Evaluation Abstract L08: Breakthrough Acute COVID-19 Infection During the US Omicron Surge Following Administration of Tixagevimab/Cilgavimab in Immunocompromised Patients with Rheumatologic Disorders

Impact of COVID 19 on Pregnancies in Women with RMD Dr. Cassy Sims discusses abstract 0950 at ACR22 Convergence. Abstract 0950: Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status: Data from the COVID-19 Global Rheumatology Alliance Registry

Photovoice: A New Visual Research Method in Lupus Dr. Bella Mehta talks with Dr. Candace Feldman about Abstract 1099 at ACR22 Convergence. Abstract 1099: Empowering Patients with Lupus Through Their Photographs: Application of the Photovoice Method to Understand Social Determinants of Health

Prescribing Methotrexate in Post-Roe Era Dr. Cassy Sims reports live from ACR22 Convergence in Philadelphia, PA.3 L09: Impact on Access to Methotrexate in the Post-Roe Era

Treatment Persistence and Switching Patterns of an Adalimumab Biosimilar Dr. Julian Segan discusses Abstract 1425 at ACR22 Convergence. Abstract 1425: Treatment Persistence and Switching Patterns of ABP 501 (AMGEVITA®) in German Patients with Rheumatic Diseases

Dr. Janet Pope discusses a debate she participated in at Eular 2024 in Vienna, Austria, and her top three messages regarding JAKi safety.

Join our live topic panel discussion!

Dr. Jack Cush reviews the journal reports from the past week on RheumNow.com. Highlights are summarized by three songs: "Stairway to Heaven", "Youre No Good", and "How Long (has this been going on)".

Dr. Yuz Yusof discusses abstract OP0092 presented at Eular 2024 in Vienna, Austria.

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.  Opioid deaths are down, IL-33 levels are up and Weight loss is in the news again this week!

- Peter Nash: 2022 ASAS/EULAR Recommendations on the Management of Axial Spondyloarthritis  https://www.youtube.com/watch?v=yp0AWs45hHo&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=34 - Robert Chao: Tapering TNFi in Psoriatic Arthritis and Axial Spondyloarthritis  https://www.youtube.com/watch?v=P-naoLl_oA8&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=40 - Peter Nash: Increasing Secukinumab Dose in Ankylosing Spondylitis Nonresponders   https://www.youtube.com/watch?v=SqBBRuirXsQ&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=35 - Janet Pope: Axial PsA: Is it for Real?   https://www.youtube.com/watch?v=AqrKxnup2LQ&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=36 - Antoni Chan: Axial PsA vs. Axial SpA  https://www.youtube.com/watch?v=t23KQvanKvQ&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=38 - Sophia Ramiro: New 2022 ASAS/EULAR Recommendations on the Management of Axial Spondyloarthritis   https://www.youtube.com/watch?v=L0ehBOrVhEw&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=1&t=15s - Antoni Chan: Update in Spondyloarthritis https://www.youtube.com/watch?v=WfNIP8vI93k&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=39 - Robert Chao: Efficacy and Safety of Bimekizumab in Psoriatic Arthritis Patients  https://www.youtube.com/watch?v=wiHZQQNLGQ8&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=41 - Aurelie Najm: TNFi in PsA and AxSpA: To Taper or Not?  https://www.youtube.com/watch?v=6bYtgJ0BfxQ&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=47&t=62s - Antoni Chan: Novel Imaging Studies in Psoriatic Arthritis https://www.youtube.com/watch?v=Te4_JwmfHrw&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=48&t=21s - Antoni Chan: Gender Differences in Axial Spondyloarthritis  https://www.youtube.com/watch?v=Jd3FN7F0F-I&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=58 - Antoni Chan: New Developments in Imaging in Spondyloarthritis - interview with  Fabian Proft  https://www.youtube.com/watch?v=aU4CcZwVa7o&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=65&t=1s

Dr. Jack Cush reviews the news and journal reports from RheumNow.com this week.

Dr Jack Cush reviews the news, journal articles and FDA warnings from the past week on RheumNow.com

Dr. Jack Cush reviews the journal reports from the past week on RheumNow.com. Highlights are summarized by three songs: "Stairway to Heaven", "Youre No Good", and "How Long (has this been going on)".  From 2.9.2024

Dr. Jonathan Kay discusses abstracts POS0620 and OP0020 presented at Eular 2024 in Vienna, Austria.

This week on RheumNow.com featuring Dr. Jack Cush

- David Liew: Can We Get Rid of RA?  https://www.youtube.com/watch?v=Dc0X6k2e1NU&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=54 - Jonathan Kay: Rheumatoid Arthritis Comorbidities  https://www.youtube.com/watch?v=1UUKeVWLVAs&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=29 - Richard Conway: Major Consequences of Depression In RA  https://www.youtube.com/watch?v=WwLUL0zYZ58&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=17&t=36s - Eric Dein: Incident Depression Major Risk Factor for Death in Rheumatoid Arthritis https://www.youtube.com/watch?v=7JyEPiY6K68&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=7 - Aurelie Najm: Treatment of Pre-RA: Is Early Already Too Late?  https://www.youtube.com/watch?v=3Cznh59mgPQ&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=9&t=8s - David Liew: Not Your Kind of RA   https://www.youtube.com/watch?v=lQt7ymAIEx0&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=11 - Richard Conway: No Glory in GLORIA   https://www.youtube.com/watch?v=VOMeRIjbdCc&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=19 - Aurelie Najm: Demystifying Synovial Tissue Biology   https://www.youtube.com/watch?v=jxePzDtEYpg&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=20 - Richard Conway: Golden Window in Pre-RA  https://www.youtube.com/watch?v=f9m0_-7MIhg&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=18 - Kathryn Dao: Methotrexate And The Sperm  https://www.youtube.com/watch?v=JK-Jqzwxpvw&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=27 - Maxime Dougados: Residual Pain in RA  https://www.youtube.com/watch?v=sJBbbU2WoNU&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=30 - Eric Dein: RA-ILD Lung Transplantation: Who Gets it and how do they do?   https://www.youtube.com/watch?v=4Uo_18gdTpY&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=46 - David Liew: Low-dose steroids: can we get rid of them?  https://www.youtube.com/watch?v=RibcAv2jpcI&list=PLbd4uixNDSBSKgUojFF3dfPfHlN8QN2EP&index=51

Moderated by Dr. Jack Cush and featuring Dr. Aurelie Najm and Dr. David Liew Recorded June 15, 2024

Sunday (Day 2): ACR 22 Daily Recap

Dr. Jack Cush reviews the news and journal reports and this week, takes on 5 cases/questions from "Ask Cush Anything"

Highlight presentations from ACR 2024 in Washington, DC Covered abstracts include: - Dr. Kavanaugh 1679 Amplified & biomarkers 0082 Enthesitis Pathology & IL-23 1553 TLR 7/8 inhibitors in SLE 995 Carbon footprint to injectables L20 ARTHUR DIANA Automated US 1132 VEGA (Combo Rx – see also 2640, 1460, 1393) 1745 Statin use in Oral Surveillance

- Dr. Cush 458 Seronegative RA fate L19 Emapalumab in Stills disease ACR 2024 updated guidelines on lupus nephritis 2580 Ianalumab in SLE 2259 Anti-Obesity Meds in RA 2657 Mortality with starting/stopping steroids 0774  TAPIR study in GCA 1697  PMR MODE study

This week, Jonathan is joined by John J Cush, from Dallas, Texas, USA. The two doctors explore novel treatment avenues for rheumatic diseases, and discuss the exciting potential of AI and telemedicine.

Rheumatologist Dr. Walter Maksymowych discusses the role of biomarkers in RA care, with a focus on 14-3-3eta as a modifiable marker for diagnosis and monitoring disease progression.

Dr. Aurelie Najm reports on abstract POS0946 presented at Eular 2024 in Vienna, Austria.

Dr. Jack Cush reviews the news and journal reports and addresses 3 viewer case questions.

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.  This week COVID persists, mortality stems from misdiagnosis, and cervical pain is more than a pain in the neck.

ALPN-303 - Dr. Pedro Castillo Dr. Castillo reports on abstract #1429 presented at the ACR21 annual meeting.

First JAKi Failure: What next? Dr. Aurelie Najm: RAPID3 in Psoriatic Arthritis: Dr. Meral El Ramahi Herpes Zoster and Rheumatoid Arthritis with Dr. Akhil Sood JAKi Safety Through the Lens of an Expert: Interview of Dr. Ernest Choy with Dr. Aurelie Najm Emerging Therapies in Psoriatic Arthritis: Drs. Antoni Chan and Oliver FitzGerald

Dr. Yuz Yusof discusses abstract OP0092 presented at Eular 2024 in Vienna, Austria.

Dr Jack Cush and his podcast friends are out to change the world. Here is his weekly review of the news and journal reports from the past week on RheumNow.com

Dr. Jack Cush reviews the news, journal articles and more from this past week on RheumNow.com

The 2023 EULAR recommendations for the management of lupus advocate for a treat-to-target approach, aiming for remission or low-level disease activity state.3 In this video, Dr. Michelle Petri summarizes the clinical criteria to attain these targets, and their association with reducing organ damage accrual.

ACR 2022 Daily Recap for Sunday, November 13th.

Comorbidities in Ankylosing Spondylitis Early Diagnosis of Axial Spondyloarthritis Fertility issues in SpA Gender in AxSpa Inadequate Dosing of Hydroxychloroquine Leads to Hospitalizations in SLE JAK inhibitors in rheumatic diseases Opioid use in PsA and SpA

Moderated by Dr. Jack Cush and featuring Dr. Bella Mehta and Dr. Antoni Chan

Dr. Jack Cush muses on the news, journal reports, FDA announcements and the 2024 BSR abstracts just released.

Dr. Jack Cush reviews the news, journal articles and RNL highlights from this past week on RheumNow.com

Best of PsA on Day 1 Can computers tell the difference between RA & PsA? Deucravacitinib in PsA Differences in Presentation and Outcomes of Early vs Late Onset PsA Opioids and Health Care Utilization in PsA and AS Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor PsA Cycling or Switching MOAs The Dietary Intervention in PsA (DIPSA) Study Ultrasound in PsA Upadacitinib vs Adalimumab in PsA using RAPID3

Join Drs. Jack Cush and Arthur Kavanaugh as they discuss highlights and key takeaways from ACR 23.

Assessment of axSpA:Dr. Antoni Chan  Defining Difficult to Manage axSpA:Dr. Lihi  DISH in SpA:Dr. Sheila Reyes Generative AI in Rheumatology: The Good, The Bad, The Ugly:Dr. Akhil Sood  Native Americans with RA Die Young:Dr. Eric Dein Precision Immunotherapy in Axial SpA:Dr. Marina Magrey  When, What and How Long to Treat GCA & PMR:Dr. Janet Pope 

QD174 - Who's to Blame QD175 - The Next Revolution QD176 - Muy Rapida Medicina QD177 - Drugs for Pregnancy Hopefuls

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.  This week neuroimmunology leading to therapy, the cold shoulder approach and Regulatory updates from the FDA

QD186 - When the Going Gets Good QD187 - Loss of Biologic Effect QD188 - PsA & LFTs RheumNow's PsA Campaign with enhanced coverage of Psoriatic Disease is sponsored by Janssen. All content is chosen by RheumNow + its faculty.

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com.

A TNR Panel discussion on controversies in PMR: diagnosis, imaging, PCP roles, Lumping vs. Splitting. Featuring Drs. Sarah Mackie, Wolfgang Schmidt, and Len Calabrese. Moderated by Dr. David Liew. Recorded on 10/24/2023

Dr. Jack Cush reviews the news, journal reports and cautions regarding COVID-19

Bimekizumab in PsA Showed Sustained Reductions in Disease Impact:Dr. Eric Dein talks with Dr. Ana-Marie Orbai  CAR-T Therapy and Lupus:Dr. Akhil Sood talks with Dr. Chris Wincup Cycling vs Switching after TNFi Failure in axSpA:Dr. Lihi Eder Difficult to manage AxSpA:Dr. Sheila Reyes talks with Dr. Denis Poddubnyy  Gender Differences in AxSpA:Dr. Adela Castro Metabolic Dysregulation and RA Interstitial Lung Disease:Dr. Mrinalini Dey  PsA Ultrasound Updates:Dr. Catherine Bakewell and Dr. Lihi Eder  SELECT-GCA: Efficacy and Safety of Upadacitinib:Dr. Richard Conway

Vitamin D and Omega-3 Fatty Acids Reduce Risk of Autoimmune Diseases: Dr. Chao Health Information Use by SLE Patients: Dr. Sheila Reyes Best of SpA Abstracts Day 2: Dr. Robert Chao Career Advice for Young Rheumatologists: Drs. Janet Pope and Vivian Bykerk Drs Antoni Chan and Oliver FitzGerald: New Therapies in Psoriatic Arthritis

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

We have two call-in cases on "Ask Cush Anything"

Be sure to join in the fun at RNL 2025 next weekend - Gong Show Karaoke; what will you sing?

Patients with axial spondyloarthritis (axSpA) commonly experience cardiovascular (CV) comorbidities. There is a need to holistically assess a patient, including considerations for managing disease activity and understanding the safety profile of available therapies as it relates to comorbidities. Join Marina Magrey, MD as she provides insight on this topic for holistic patient-centered care. 

Please provide feedback on the session using this link https://bit.ly/3j4pA6u

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com

QD170 - Shared Decision Making in PsA QD171 What To Do With the NSAID? QD172 - The Differential on Tenosynovitis QD173 - Doctors in the Dark

Panel discussion on treatment options beyond steroids in PMR. Featuring Drs. Sebastian Sattui, Sarah Mackie, Anisha Dua, Robert Spiera and David Liew. Recorded on 10/17/2023

Dr. Aurelie Najm reports from Eular 2024 in Vienna, Austria, about abstracts OP0072 and OP0086.

QD165 - Referring Psoriasis with Joint Pain   https://youtu.be/ioyHELvAzz4 QD166 - Phone calls about labs  https://youtu.be/uAvOkahIWiM QD167 -  When Labs and Exam are Discordant  https://youtu.be/dTLt7VoGubA QD168 - Rheumatoid Arthritis and Eosinophilia  https://youtu.be/gIHOohWLWFs QD169 - Another Kind of COVID Discussion   https://youtu.be/cVdvvRSh6WA

A New ACR Anti IL-17 on Entheseal Biopsy in PsA axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure Best Things I Saw Today in PsA Cycling vs Switching after TNFi Failure in axSpA Improvements in Pain and Fatigue in Bimekizumab Long-term Safety Profile of Bimekizumab in axSpA and PsA Sonelokimab in PsA: Phase 2 Data Treating SpA

Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021.

My Top 10 list 1. New FDA Approvals: voclosporin, anifrolumab, avacopan, efgartigimod  2. New FDA Indications 3.  New Biologics for Lupus 4. Super "H" Hydroxychloroquine 5. Zoomatology 6. Avacopan 7. Tocilizumab 8. FDA & JAK inhibitor warnings 9. New Biologics for GCA 10. IL-23 Inhibitors

https://rheumnow.com/news/2021-rheumatology-year-review-172022

Dr Jack Cush reviews the news, journal reports and FDA approvals from the past week on RheumNow.com

Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis? Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria:

OP0195 Sonelokimab IL 17 A/F nanobody inhibitor LB0005 Izokibep IL17A nanobody inhibitor POS0803 Vunakizumab, another IL17A inhibitor OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib

Do MRI changes at the Spine and SI Joints in Treatment of AxSpA Matter? Dr. Eric Ruderman discusses abstracts OP0046 and POS0058 presented at Eular 2024 in Vienna, Austria.

OP0046 Effect on SI joint structural lesions with ixekizumab POS0058 Effect on SI joint structural lesions with bimekizumab

Does Telemonitoring in SpA Work? Dr. Antoni Chan reports on abstract OP0120 from Eular 2024 in Vienna, Austria.

Potential of Radiomics to Predict TNF Therapy Outcomes in axSpA Dr. Bella Mehta interviews Dr. Vincenzo Venerito about abstract POS0236 at Eular 2024 in Vienna, Austria.

Treat to Target Outcomes in Early AxSpA Dr. Antoni Chan discusses abstract OP0132 presented at Eular 2024 in Vienna, Austria.

Early Diagnosis of Axial Spondyloarthritis Dr. Antoni Chan reports on abstract OP0310 presented at Eular 2024 in Vienna, Austria.

Imaging in Axial Spondyloarthritis Dr. Antoni Chan reviews abstracts OP0222 and OP0303 presented at Eular 2024 in Vienna, Austria.

Cannabinoid Receptor in RA Patients Cardiac Troponin T and MACE Events in RA Imaging Updates in SpA Impact of Tofacitinib on Skeletal Muscle in RA Teledidactic vs On Campus Training in Musculoskeletal Ultrasound Treatments in SpA

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com

Expert-Selected EULAR 2021 Abstracts Sponsored by Novartis Medical Affairs 

Didn’t have time to join EULAR 2021? Listen to a panel of experts as they present their views on the key abstracts in SpA and Still’s disease. 

Provide feedback on these videos by completing the survey: https://bit.ly/3xPW5dG

Join our live stream panel discussion as we dive deep into the highlights and key takeaways from day one of ACR 2023.

Features presentations by Drs. Jack Cush, Rachel Tate, Sheila Reyes, Yuz Yusof and Robert Chao.  Discussing the following abstracts from ACR 2023:

- 0494 Occult IBD in SpA

 -0781 Combination therapy and reduced dose prednisone in SLE

- 0723 TRAF5 and PAH in SLE

- 0845  Repeat MRI and testing in LBP patients

-0836 Imposter syndrome

- 0548 ANA+ referral approaches

- CNS Vasculitis

- 0835 APIPPRA

- 0839 TLL-018 in RA

Dr. Jonathan Kay discusses abstracts POS0070, POS0043 and POS0022 presented at the Eular 2024 meeting in Vienna, Austria.

Join us for session highlights from RheumNow Live 2022. This webinar will feature highlights from these lectures followed by live audience Q & A:

Advances in Psoriasis Management Bruce Strober, MD, PhD

Psoriasis Management Cases Kenneth Gordon, MD

Co-management of Psoriasis and PsA Joseph Merola, MD

Glucocorticoids and CV risk in RA: Drs. Aurelie Najm and Jon Giles Might Tofacitinib Reduce Malignancy Risk with Patients with RA? Dr. Jonathan Kay Rheumatic Diseases Can Take your Breath Away: Dr.Janet Pope Best of PsA Day 4 (Tuesday): MACE in PsA:  Dr. Rachel Tate Predicting Progression from Psoriasis to PsA: Dr. Robert Chao David Liew Interview Dr. Seoyoung Kim About Tofacitinib and Malignancy Risk. Third Time's the Charm - COVID Vaccination While on Rituximab: Dr. Yuz Yusof Can We Stop Medication in Systemic JIA? Dr. Bella Mehta Day 4 SpA Highlights - Pregnancy in SpA and Drug Monitoring: Dr. Robert Chao

Dr. Jack Cush is joined by Drs. Roy Fleischmann (Dallas), Allan Gibofsky (NYC), and Artie Kavanaugh (San Diego)

Aging Gracefully in Managing Rheumatic Diseases:Dr. Mrinalini Dey interviews Dr. Elena Myasoedova Apremilast Benefits and Risks in PsA:Dr. Akhil Sood  Assessing ASAS Criteria: CLASSIC Study Results:Dr. Adela Castro Assessment and management of axSpA:Dr. Antoni Chan Disease Activity in RA-ILD:Dr. Richard Conway Finding the Right Combination Therapy in RA:Dr. Jonathan Kay interviews Dr. Ernest Choy Highlights in axSpA:Dr. Marina Magrey Hot Topics in axSpA:Dr. Marina Magrey Proposed ACR Guidance for Use of MSUS in Psoriatic Arthritis:Dr.  Antoni Chan interviews Dr. Catherine Bakewell PsA Potpourri:Dr. Arthur Kavanaugh RA Treatment Adherence: Is decision making really shared?:Dr. Jonathan  Kay interviews Dr. Cécile Gaujoux-Viala RA: One JAK to Rule Them All?:Dr. Brian Jaros What is a Positive MRI in Spondyloarthritis?:Dr. Sheila Reyes interviews Dr. Walter Maksymowych

Effect of Ancestry on Therapeutic Outcomes in SLE  Dr. Yuz Yusof   https://youtu.be/QqthOjDxePE De Novo Renal Nephritis Flares During Belimumab Trials  Drs. Yuz Yusof and Iaonnis Parodis   https://youtu.be/BYORFgYOdcI Update on CAR T Cell Therapy in SLE & Autoimmune Diseases  Dr. Peter Nash   https://youtu.be/KnHRgaEcqGc  We should put the CART before the T in SLE!  Dr. Janet Pope  https://youtu.be/carHG-5mFmQ Changes in the Causes and Predictors of Lupus Mortality in Spain  Dr. Bella Mehta  https://youtu.be/Yzm4twLAWfI JAK/TYK Inhibitors in SLE  Dr. Janet Pope   https://youtu.be/3wy5pOpbyPY Upadacitinib in SLE  Dr. Peter Nash    https://youtu.be/eqnXUrgpWdM SLE Trial: Dual BTK JAK Blockade compared Upadacitinib Monotherapy Dr. Yuz Yusof   https://youtu.be/yTmQTA7yU8U Efficacy and Safety of Baricitinib in Lupus Nephritis  Dr. Yuz Yusof  https://youtu.be/DgTIdAlhK_s Baricitinib in Lupus Nephritis  Dr. Peter Nash  https://youtu.be/qyhMHyYKuTU

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.  He discusses the GI side effects of IL-17 inhibitors, downstream revenues from rheumatology care and dietary prevention of gout.

Dr Jack Cush reviews rheumatology and COVID news from the past week on RheumNow.com

- Steroid Tapering in PMR: What's the Gold Standard? Dr. Anisha Dua  https://youtu.be/7tYNlKpGzoA?si=xNbwVDlv8NknxqoC - Should We be Giving IL-6 Inhibitors Late in PMR, or Early? Dr. Robert Spiera   https://youtu.be/Ms7VDp5_MEc?si=JtDoxioB8rXslsRh - Universal Imaging for GCA in PMR? Not so fast!  Dr. Michael Putman  https://youtu.be/VNCdiG7aaJ8?si=O2Dp4z6BI0WtDrLZ - Advancing PMR.  Dr. Eric Matteson  https://youtu.be/A1uNGBMp8Lk?si=-HOV1hpW0s4p7qUj

Moderated by Dr. Jack Cush and featuring Drs. Aurelie Najm, David Liew and Jonathan Kay

Join us for session highlights from RheumNow Live 2023. This webinar will feature highlights from these lectures followed by live audience Q & A:

Remission in Psoriatic Arthritis Laura Coates, MBBS University of Oxford

JAK inhibitors in Psoriasis and PsA Eric Ruderman, MD Northwestern University Feinberg School of Medicine

Pregnancy in PsA Christina Chambers, PhD, MPH

This week on the podcast Dr. Jack Cush reviews the news, regulatory announcements and novel journal reports including a profile on pseudogout, the safety of immune checkpoint inhibitors in RA patients and the diagnostic importance of neutrophils.

Head to Head Comparison of Tofacitinib and TLL-018 in RA Non-TNFi b_tsDMARDs vs. TNFi in RA-ILD People with RA and Long COVID Had Worse Pre-COVID RA Symptoms Reproductive History, HPV Vaccination Among Women with SLE and  RA Secukinumab vs. Adalimumab Biosimilar on Radiographic Progression in AxSpA The SMART Study_ Split Dose Oral Methotrexate Undiagnosed IBD in AxSpA Using Telemedicine to Improve Diagnosis of AxSpA Window of Opportunity in PsA

Dr. Jack Cush reviews the big PMR reports from this week along with other journal reports from RheumNow.com

EULAR 2024 RECAP DAY 3 Moderated by Dr. Jack Cush with Drs. Bella Mehta and Antoni Chan.

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com, noting his concerns about diet, cancer, ILD, death and dosing challenges.

Dr. Jack Cush reviews the top abstracts from EULAR 2022

Dr. Jack Cush reviews highlights from RheumNow Live 2025 held in Dallas, TX on Feb. 8-9, 2025